Invention Grant
- Patent Title: Anti-DLL3 antibody drug conjugates and methods of use
- Patent Title (中): 抗DLL3抗体药物偶联物及其使用方法
-
Application No.: US14742576Application Date: 2015-06-17
-
Publication No.: US09133271B1Publication Date: 2015-09-15
- Inventor: Robert A. Stull , Laura Saunders , Scott J. Dylla , Orit Foord , David Liu , Michael Torgov , Hui Shao
- Applicant: Stemcentrx, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Stemcentrx, Inc.
- Current Assignee: Stemcentrx, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Womble Carlyle Sandridge & Rice, LLP
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/18 ; C12P21/08 ; A61K47/48 ; A61K31/5517
Abstract:
Provide are novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat recurrent tumors and to reduce or inhibit tumor recurrence in a subject.
Information query
